Patents Assigned to Peptera Pharmaceuticals Ltd
  • Patent number: 7741274
    Abstract: Biologically active peptides that are derived from or are similar to sequences identical with the N-terminus of the oS1 fraction of milk casein. These peptides are capable of stimulating and enhancing immune response, protecting against viral infection, normalizing serum cholesterol levels, and stimulating hematopoiesis. The casein-derived peptides are non-toxic and can be used to treat and prevent immune pathologies, hypercholesterolemia, hematological disorders and viral-related diseases.
    Type: Grant
    Filed: September 8, 2006
    Date of Patent: June 22, 2010
    Assignee: Peptera Pharmaceuticals Ltd.
    Inventor: Zvi Sidelman
  • Patent number: 7666996
    Abstract: Biologically active peptides that are derived from or are similar to sequences identical with the N-terminus of the ?S1 fraction of milk casein. These peptides are capable of stimulating and enhancing immune response, protecting against viral infection, normalizing serum cholesterol levels, and stimulating hematopoiesis. The casein-derived peptides are non-toxic and can be used to treat and prevent immune pathologies, hypercholesterolemia, hematological disorders and viral-related diseases, alone or in combination with other peptides or blood cell stimulating factors.
    Type: Grant
    Filed: March 1, 2004
    Date of Patent: February 23, 2010
    Assignee: Peptera Pharmaceuticals Ltd
    Inventor: Zvi Sidelman